These data, in addition to shedding light on the functions of the adipokine leptin and providing new insights into the regulation of the Notch pathway in GBM, suggest that targeting leptin–Notch signaling interaction could be a potential novel therapeutic option to treat GBM. The gene discussed is LEP; the disease is glioblastoma.